Form 4 for TLSI TriSalus Life Sciences, Inc.
Accepted 2024-02-14 00:00:00 ET · period of report 2024-02-12 · accession 0001415889-24-003807 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-14 | 2024-02-12 | TLSI | Devlin Jodi | Pres, COMMERC. Ops | A - Grant | $0.00 | +17.5K | 17.5K | New | $0 |
| D | 2024-02-14 | 2024-02-12 | TLSI | Devlin Jodi | Pres, COMMERC. Ops | A - Grant | $0.00 | +105.0K | 105.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-12 | A | A | 17,500 | $0.00 | 17,500 | D | — | — | (F1) Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on February 12, 2024, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2024-02-12 | A | A | 105,000 | $0.00 | 105,000 | D | $9.50 · — to 2034-02-11 | 105,000 Common Stock | (F2) One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of February 12, 2024, and 1/36th of the remaining shares shall vest each month thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. |